IO NewsWire

November 16, 2010 07:30 ET

(OTCBB: MFTH) Patented Technology Aims at Reducing Unauthorized Drug Administration

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO News Wire

NEW YORK, NY--(Marketwire - November 16, 2010) - Medisafe 1 Technologies Corp. (OTCBB: MFTH), a patent holder of a unique locking mechanism for hypodermic needles, has recently announced the tremendous attention it received at the HealthAchieve Conference on November 8th through the 10th.

Wrongful medication administration has been estimated at nearly 8,000 deaths a year in the US alone. Medication errors account for 1 in 131 outpatient deaths and 1 in 854 inpatient deaths.

But utilizing Medisafe 1 technology, hospitals and care givers can help reduce the number of deaths by ensuring the correct dosage and drug is given to the right patient.

For more information please visit

Other active stocks are Unilife (NASDAQ: UNIS) Sharps Compliance Corp (NASDAQ: SMED) and Fidelis Energy Inc (OTC: FDEI)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information